IL-22

1 stories · following the connections

Business

PROVECTUS ANNOUNCES RESULTS FROM MECHANISM OF ACTION STUDY OF TOPICAL PH-10 FOR THE TREATMENT OF PSORIASIS

By Nasdaq OMXNov 30, 2017, 11:00 AM UTC